|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Total net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| FHLB stock dividends | |||||
| Provision for credit losses | |||||
| Deferred income taxes | |||||
| Restricted stock expense | |||||
| Increase in cash value of life insurance | |||||
| Amortization and accretion, net, related to acquisitions | |||||
| Bank premises and equipment loss/(gain) | |||||
| Securities loss (gain) | |||||
| Change in value of equity securities | |||||
| Loss on sale/writedown of other real estate | |||||
| Residential loans originated and held for sale | |||||
| Proceeds from sale of residential loans held for sale | |||||
| Changes in: | |||||
| Interest receivable | |||||
| Other assets | |||||
| Interest payable | |||||
| Operating lease liability | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Available-for-sale securities: | |||||
| Sales | |||||
| Maturities, prepayments, and calls | |||||
| Purchases | |||||
| Held-to-maturity securities: | |||||
| Maturities, prepayments, and calls | |||||
| Purchases | |||||
| Purchase of other securities | |||||
| Purchase of equity securities | |||||
| Proceeds from redemption of other securities | |||||
| Net (increase)/decrease in loans | |||||
| Net changes to premises and equipment | |||||
| Bank-owned life insurance - death proceeds | |||||
| Purchase of bank owned life insurance | |||||
| Proceeds from sale of other real estate owned | |||||
| Proceeds from sale of premises and equipment | |||||
| Cash received in excess of cash paid for acquisition | |||||
| Net cash (used in) provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Increase/(decrease) in deposits | |||||
| Net change in borrowed funds | |||||
| Proceeds from borrowed funds | |||||
| Repayment of borrowed funds | |||||
| Total net change in borrowed funds | |||||
| Dividends paid on common stock | |||||
| Cash paid to repurchase common stock | |||||
| Repurchase of restricted stock for payment of taxes | |||||
| Principal payment on finance lease liabilities | |||||
| Issuance of subordinated debt, net | |||||
| Payment on subordinated debt issuance costs | |||||
| Called/repayment of subordinated debt | |||||
| Net cash (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures: | |||||
| Interest | |||||
| Income taxes, net of refunds | |||||
| Non-cash activities: | |||||
| Transfers of loans to other real estate | |||||
| Transfer of securities available-for-sale to held-to-maturity | |||||
| Issuance of restricted stock grants | |||||
| Common Stock | |||||
| Total issuance of restricted stock grants | |||||
| Stock issued | |||||
| Issuance of shares for SWG acquisition | |||||
| BBI Acquisition | |||||
| HSBI | |||||
| Common Stock | |||||
| Total stock issued | |||||
| Dividends on restricted stock grants | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Lease liabilities arising from BBI acquisition | |||||
| BBI Acquisition | |||||
| HSBI | |||||
| Total lease liabilities arising from BBI acquisition | |||||
| Lease liabilities arising from acquisition | |||||
| BBI Acquisition | |||||
| HSBI | |||||
Loading...